Navigation Links
Environmental risk assessment of pharmaceuticals inadequate
Date:10/18/2010

The strategies used to assess the environmental risks posed by pharmaceuticals are not enough to protect natural microbial communities, reveals a researcher from the University of Gothenburg (Sweden) who is calling for better environmental risk assessments.

"Above all, we need to include the combined effects of different drugs to reflect the situation in nature as it really is," says Sara Brosch from the Department of Plant and Environmental Sciences at the University of Gothenburg.

Modern medicine relies on pharmaceuticals for the treatment of practically everything, from headaches to cancer. The active substances in the drugs we take do not disappear into the body but are gradually secreted in urine and faeces. They then enter the sewerage system, and small amounts make it through the entire sewage treatment process.

Small quantities of pharmaceuticals are nowadays found in most aquatic environments, from groundwater to seawater. The highest concentrations are in the effluent from sewage treatment plants, often in the form of a cocktail of many different drugs. Once out in nature, these drug residues continue to affect living creatures. This applies particularly to antimicrobial agents such as antibiotics and antifungals, which are designed to kill microorganisms whether they are "bad" and cause infection, or "good" and serve important functions in nature.

"I saw effects on bacteria from the antibiotic chlortetracycline even at the concentrations shown in scientific publications to be present in the effluent from sewage treatment plants. Although chlortetracycline is no longer used in Sweden, many antibiotics from the same class are still in use."

In her research, Brosch has looked primarily at the combined effects of pharmaceuticals, as a cocktail of toxic substances will generally have a greater effect than the sum of its constituent parts. Her results show that although the levels of drugs normally seen in the environment are low, they are not without their risks.

"When five pharmaceuticals and personal care products (fluoxetine, propranolol, zinc pyritione, clotrimazole and triclosan) were mixed together at concentrations which did not have any significant effect individually, the mixture had an almost 30% effect on microalgae."

Brosch has also studied the high levels of antibiotics in effluents from pharmaceutical production in India. When microbial communities were exposed to this effluent, they rapidly developed increased tolerance to the antibiotic ciprofloxacin.


'/>"/>

Contact: Sara Brosch
sara.brosche@dpes.gu.se
46-704-035-816
University of Gothenburg
Source:Eurekalert

Related biology news :

1. Lack of large-scale experiments slows progress of environmental restoration
2. MU scientists go green with gold, distribute environmentally friendly nanoparticles
3. Growing a garden of future environmental leaders
4. Alternative to burning: environmentally sound disposal for wood chips
5. Childrens gardening programs grow environmental stewards
6. New center will focus environmental debate and produce solutions for action
7. 6 environmental research studies reveal critical health risks from plastic
8. Experts agree: Environmental standards needed for biofuels
9. Yale journal finds nanomaterials may have large environmental footprint
10. Childhood environmental health
11. North American environmental commission launches trinational vaquita conservation plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... , December 22, 2016 SuperCom (NASDAQ: ... secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors ... SuperCom, has been selected to implement and deploy a community-based supportive ... Northern California , further expanding its presence in the ... This new ...
(Date:12/20/2016)... RALEIGH, N.C. and GENEVA, Dec, 20, 2016 ... performance biometric data sensor technology, and STMicroelectronics ... across the spectrum of electronics applications, announced today ... scalable development kit for biometric wearables that includes ... integrated with Valencell,s Benchmark™ biometric sensor ...
(Date:12/16/2016)... Dec. 16, 2016   IdentyTechSolutions America LLC ... products and solutions and a cutting-edge manufacturer of ... it is offering seamless, integrated solutions that comprise ... products. The solutions provide IdentyTech,s customers with combined ... facilities from crime and theft. "We ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017 Roka Bioscience, Inc. (NASDAQ: ... solutions for the detection of foodborne pathogens today announced the appointment ... succeeds Paul Thomas , the Company,s President and CEO since ... Board of Directors.  The changes are effective today. In ... today. ...
(Date:1/17/2017)... DUBLIN , Jan. 17, 2017 ... new report "Molecular Diagnostics - Technologies, Markets and Companies" ... ... molecular diagnostics has increased remarkably during the past few years. ... in developing molecular diagnostics and 342 of these are profiled ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body wellness ... announced today the official launch of its much-anticipated Pono Board: a re-invented fitness and ... In development for over a year, the patented Pono Board is the world’s only ...
(Date:1/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... initiated a global Phase 2b induction study in ... targets alpha4beta7 integrin. The aim of this randomized, ... the safety/tolerability and efficacy of PTG-100 in approximately ... severe active disease. "We are ...
Breaking Biology Technology: